問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2013-09-01 - 2024-03-31
Condition/Disease
Nonmetastatic Castration Resistant Prostate Cancer
Test Drug
Enzalutamide
Participate Sites11Sites
Terminated11Sites
2024-09-01 - 2028-12-31
Participate Sites14Sites
Recruiting14Sites
2025-06-01 - 2029-04-30
Participate Sites6Sites
Recruiting6Sites
2023-04-17 - 2026-12-31
Participate Sites8Sites
Recruiting8Sites
2019-05-01 - 2025-12-31
Participate Sites4Sites
Recruiting4Sites
2020-02-05 - 2026-12-31
Participate Sites9Sites
Recruiting9Sites
2025-09-01 - 2032-12-31
2024-02-01 - 2026-04-30
Participate Sites5Sites
Recruiting5Sites
2025-03-01 - 2029-03-01
Pre-fibrotic/Early Primary Myelofibrosis or Overt Primary Myelofibrosis at Low or Intermediate-1 Risk According to DIPSS Plus (HOPE-PMF): The Core Study and Its Extension Study
injection
2025-03-01 - 2026-09-30
Participate Sites2Sites
Recruiting2Sites
全部
